Anebulo Pharmaceuticals Stock Price Prediction
| ANEB Stock | USD 3.04 0.09 3.05% |
Oversold Vs Overbought
47
Oversold | Overbought |
Anebulo Pharmaceuticals stock price prediction is an act of determining the future value of Anebulo Pharmaceuticals shares using few different conventional methods such as EPS estimation, analyst consensus, or fundamental intrinsic valuation. The successful prediction of Anebulo Pharmaceuticals' future price could yield a significant profit. Please, note that this module is not intended to be used solely to calculate an intrinsic value of Anebulo Pharmaceuticals and does not consider all of the tangible or intangible factors available from Anebulo Pharmaceuticals' fundamental data. We analyze noise-free headlines and recent hype associated with Anebulo Pharmaceuticals, which may create opportunities for some arbitrage if properly timed.
Below are the key fundamental drivers impacting Anebulo Pharmaceuticals' stock price prediction:EPS Estimate Next Quarter (0.10) | EPS Estimate Current Year (0.45) | EPS Estimate Next Year (0.55) | Wall Street Target Price 6 |
It is a matter of debate whether stock price prediction based on information in financial news can generate a strong buy or sell signal. We use our internally-built news screening methodology to estimate the value of Anebulo Pharmaceuticals based on different types of headlines from major news networks to social media. The Anebulo stock price prediction module provides an analysis of price elasticity to changes in media outlook on Anebulo Pharmaceuticals over a specific investment horizon. Using Anebulo Pharmaceuticals hype-based prediction, you can estimate the value of Anebulo Pharmaceuticals from the perspective of Anebulo Pharmaceuticals response to recently generated media hype and the effects of current headlines on its competitors.
This module is based on analyzing investor sentiment around taking a position in Anebulo Pharmaceuticals. This speculative approach is based exclusively on the idea that markets are driven by emotions such as investor fear and greed. The fear of missing out, i.e., FOMO, can cause potential investors in Anebulo Pharmaceuticals to buy its stock at a price that has no basis in reality. In that case, they are not buying Anebulo because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell stocks at prices well below their value during bear markets because they need to stop feeling the pain of losing money.
Anebulo Pharmaceuticals after-hype prediction price | USD 3.04 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Anebulo |
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Anebulo Pharmaceuticals' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Anebulo Pharmaceuticals After-Hype Price Prediction Density Analysis
As far as predicting the price of Anebulo Pharmaceuticals at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Anebulo Pharmaceuticals or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Stock prices, such as prices of Anebulo Pharmaceuticals, with the unreliable approximations that try to describe financial returns.
Next price density |
| Expected price to next headline |
Anebulo Pharmaceuticals Estimiated After-Hype Price Volatility
In the context of predicting Anebulo Pharmaceuticals' stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Anebulo Pharmaceuticals' historical news coverage. Anebulo Pharmaceuticals' after-hype downside and upside margins for the prediction period are 0.15 and 7.09, respectively. We have considered Anebulo Pharmaceuticals' daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
Anebulo Pharmaceuticals is very risky at this time. Analysis and calculation of next after-hype price of Anebulo Pharmaceuticals is based on 3 months time horizon.
Anebulo Pharmaceuticals Stock Price Prediction Analysis
Have you ever been surprised when a price of a Company such as Anebulo Pharmaceuticals is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Anebulo Pharmaceuticals backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Anebulo Pharmaceuticals, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
0.39 | 4.07 | 0.02 | 0.07 | 4 Events / Month | 5 Events / Month | In about 4 days |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | ||
3.04 | 3.04 | 0.00 |
|
Anebulo Pharmaceuticals Hype Timeline
Anebulo Pharmaceuticals is presently traded for 3.04. The entity has historical hype elasticity of -0.02, and average elasticity to hype of competition of 0.07. Anebulo is forecasted not to react to the next headline, with the price staying at about the same level, and average media hype impact volatility is over 100%. The immediate return on the next news is forecasted to be very small, whereas the daily expected return is presently at 0.39%. %. The volatility of related hype on Anebulo Pharmaceuticals is about 2442.0%, with the expected price after the next announcement by competition of 3.11. About 65.0% of the company shares are held by company insiders. The company recorded a loss per share of 0.41. Anebulo Pharmaceuticals had not issued any dividends in recent years. Given the investment horizon of 90 days the next forecasted press release will be in about 4 days. Check out Anebulo Pharmaceuticals Basic Forecasting Models to cross-verify your projections.Anebulo Pharmaceuticals Related Hype Analysis
Having access to credible news sources related to Anebulo Pharmaceuticals' direct competition is more important than ever and may enhance your ability to predict Anebulo Pharmaceuticals' future price movements. Getting to know how Anebulo Pharmaceuticals' peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Anebulo Pharmaceuticals may potentially react to the hype associated with one of its peers.
| HypeElasticity | NewsDensity | SemiDeviation | InformationRatio | PotentialUpside | ValueAt Risk | MaximumDrawdown | |||
| ADAG | Adagene | (0.01) | 4 per month | 0.00 | (0.12) | 5.65 | (8.42) | 30.26 | |
| ACRV | Acrivon Therapeutics Common | 0.70 | 7 per month | 5.57 | 0.15 | 18.20 | (10.84) | 73.69 | |
| ANAB | AnaptysBio | 0.92 | 9 per month | 3.67 | 0.05 | 11.29 | (6.34) | 22.98 | |
| MLYS | Mineralys Therapeutics Common | (0.26) | 7 per month | 3.08 | 0.03 | 6.18 | (5.15) | 22.93 | |
| AVTE | Aerovate Therapeutics | 0.30 | 9 per month | 5.02 | 0.05 | 11.11 | (8.70) | 28.53 | |
| OPT | Opthea | (0.19) | 11 per month | 3.12 | 0.07 | 8.00 | (6.25) | 19.28 | |
| ANTX | AN2 Therapeutics | 0.06 | 11 per month | 0.00 | (0.21) | 4.07 | (9.57) | 77.39 | |
| PMVP | Pmv PharmaceuticalsInc | 0.01 | 7 per month | 3.93 | 0.06 | 6.67 | (6.63) | 21.67 | |
| MOLN | Molecular Partners AG | (0.03) | 5 per month | 0.00 | (0.09) | 5.67 | (7.64) | 26.69 |
Anebulo Pharmaceuticals Additional Predictive Modules
Most predictive techniques to examine Anebulo price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Anebulo using various technical indicators. When you analyze Anebulo charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
About Anebulo Pharmaceuticals Predictive Indicators
The successful prediction of Anebulo Pharmaceuticals stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as Anebulo Pharmaceuticals, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of Anebulo Pharmaceuticals based on analysis of Anebulo Pharmaceuticals hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to Anebulo Pharmaceuticals's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Anebulo Pharmaceuticals's related companies. | 2021 | 2022 | 2023 | 2024 (projected) | Current Ratio | 28.39 | 21.04 | 24.2 | 40.06 | Net Debt To EBITDA | 2.13 | 0.95 | 1.1 | 1.04 |
Story Coverage note for Anebulo Pharmaceuticals
The number of cover stories for Anebulo Pharmaceuticals depends on current market conditions and Anebulo Pharmaceuticals' risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Anebulo Pharmaceuticals is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Anebulo Pharmaceuticals' long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.
Contributor Headline
Latest Perspective From Macroaxis
View All Premium Stories
Anebulo Pharmaceuticals Short Properties
Anebulo Pharmaceuticals' future price predictability will typically decrease when Anebulo Pharmaceuticals' long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of Anebulo Pharmaceuticals often depends not only on the future outlook of the potential Anebulo Pharmaceuticals' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Anebulo Pharmaceuticals' indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 25.1 M | |
| Cash And Short Term Investments | 11.2 M | |
| Shares Float | 3.9 M |
Check out Anebulo Pharmaceuticals Basic Forecasting Models to cross-verify your projections. For information on how to trade Anebulo Stock refer to our How to Trade Anebulo Stock guide.Note that the Anebulo Pharmaceuticals information on this page should be used as a complementary analysis to other Anebulo Pharmaceuticals' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Comparator module to compare the composition, asset allocations and performance of any two portfolios in your account.
Complementary Tools for Anebulo Stock analysis
When running Anebulo Pharmaceuticals' price analysis, check to measure Anebulo Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Anebulo Pharmaceuticals is operating at the current time. Most of Anebulo Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Anebulo Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Anebulo Pharmaceuticals' price. Additionally, you may evaluate how the addition of Anebulo Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio |
Is Anebulo Pharmaceuticals' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Anebulo Pharmaceuticals. If investors know Anebulo will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Anebulo Pharmaceuticals listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.41) | Return On Assets (0.55) | Return On Equity (0.95) |
The market value of Anebulo Pharmaceuticals is measured differently than its book value, which is the value of Anebulo that is recorded on the company's balance sheet. Investors also form their own opinion of Anebulo Pharmaceuticals' value that differs from its market value or its book value, called intrinsic value, which is Anebulo Pharmaceuticals' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Anebulo Pharmaceuticals' market value can be influenced by many factors that don't directly affect Anebulo Pharmaceuticals' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Anebulo Pharmaceuticals' value and its price as these two are different measures arrived at by different means. Investors typically determine if Anebulo Pharmaceuticals is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Anebulo Pharmaceuticals' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.